Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026

Image for article Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026
News Source : Financial Post

News Summary

  • Definium Therapeutics, Inc. (NASDAQ: DFTX) announces additional details for its Investor & Analyst Day in New York on April 22, 2026.
  • Presentations and live question and answer sessions will be led by members of the executive leadership team and external key opinion leaders.
  • Key areas of discussion will include DT120 ODT (lysergide tartrate), Definium’s lead investigational program in Phase 3 development for GAD and MDD.
NEW YORK Definium Therapeutics, Inc. (NASDAQ DFTX), a latestage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric a [+4967 chars]

Must read Articles